Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood. (Q48399619)

11 February 2018

title

Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood. (English)

1 reference

11 February 2018

author

Viviane Van Hoof

11

1 reference

11 February 2018

Hugo A. Katus

3

object named as

Hugo A Katus

1 reference

11 February 2018

author name string

Christian Zugck

1

1 reference

11 February 2018

Manfred Nelles

2

1 reference

11 February 2018

Paul O Collinson

4

1 reference

11 February 2018

David C Gaze

5

1 reference

11 February 2018

Bert Dikkeschei

6

1 reference

11 February 2018

Eberhard Gurr

7

1 reference

11 February 2018

Wiebke Hayen

8

1 reference

11 February 2018

Markus Haass

9

1 reference

11 February 2018

Christoph Hechler

10

1 reference

11 February 2018

Khadija Guerti

12

1 reference

11 February 2018

Carl van Waes

13

1 reference

11 February 2018

Gert Printzen

14

1 reference

11 February 2018

Kai Klopprogge

15

1 reference

11 February 2018

Ilse Schulz

16

1 reference

11 February 2018

Rainer Zerback

17

1 reference

11 February 2018

publication date

1 January 2006

1 reference

11 February 2018

Clinical Chemistry and Laboratory Medicine

published in

1 reference

11 February 2018

volume

44

1 reference

11 February 2018

page(s)

1269-1277

1 reference

11 February 2018

issue

10

1 reference

11 February 2018

N-terminal brain natriuretic peptide, but not anemia, is a powerful predictor of mortality in advanced heart failure.

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

Effect of different sample types and stability after blood collection of N-terminal pro-B-type natriuretic peptide as measured with Roche Elecsys system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

Multicenter analytical performance evaluation of the Elecsys proBNP assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

NT-proBNP and BNP: biomarkers for heart failure management

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

The prediction of in-hospital mortality by amino terminal pro-brain natriuretic peptide (NT-proBNP) levels and other independent variables in acutely ill patients with suspected heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

Lifetime Risk for Developing Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.215

21 January 2018

Identifiers

DOI

10.1515/CCLM.2006.215

1 reference

11 February 2018

PubMed ID

17032141

1 reference

11 February 2018